A Phase 2 Study of the Safety and Efficacy of Oral Delafloxacin (DLX) in Community Acquired Pneumonia (CAP)
Latest Information Update: 26 Nov 2012
At a glance
- Drugs Delafloxacin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2012 New trial record